Kim Altman Weiss

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Frédérique Bard, Catherine Cannon, Robin Barbour et al. · Nature Medicine · 2000 · 2K citations · Full text

Amyloid β-Peptide Enter, Neurodegenerative Diseases, Alzheimer's Disease +13

Quality of life in schizophrenia: contributions of anxiety and depression

Jonathan D. Huppert, Kim Altman Weiss, Rosa Lim et al. · Schizophrenia Research · 2001 · 254 citations

Quality Of Life, Life Satisfaction, Psychopathology +10

Predictors of Risk of Nonadherence in Outpatients With Schizophrenia and Other Psychotic Disorders

Kim Altman Weiss, Thomas E. Smith, J. W. Hull et al. · Schizophrenia Bulletin · 2002 · 133 citations · Full text

Other Psychotic Disorders, Family Medicine, Epidemiology +14

Symptoms and Neurocognition as Rate Limiters in Skills Training for Psychotic Patients

Thomas E. Smith, James W. Hull, Susan Romanelli et al. · American Journal of Psychiatry · 1999 · 82 citations

Developmental Screening of Children Diagnosed with Congenital Heart Defects

Stacey Weinberg, Jeffrey H. Kern, Kim Altman Weiss et al. · Clinical Pediatrics · 2001 · 20 citations

Heart Failure, Cardiovascular Disease, Pediatric Heart Disease +12